• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用连续血糖监测传感器评估1型糖尿病患者血糖控制质量时血糖管理指标的效用:一项横断面多中心研究

The Usefulness of the Glucose Management Indicator in Evaluating the Quality of Glycemic Control in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring Sensors: A Cross-Sectional, Multicenter Study.

作者信息

Lazar Sandra, Potre Ovidiu, Ionita Ioana, Reurean-Pintilei Delia-Viola, Timar Romulus, Herascu Andreea, Avram Vlad Florian, Timar Bogdan

机构信息

First Department of Internal Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Department of Hematology, Emergency Municipal Hospital, 300254 Timisoara, Romania.

出版信息

Biosensors (Basel). 2025 Mar 16;15(3):190. doi: 10.3390/bios15030190.

DOI:10.3390/bios15030190
PMID:40136987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11940097/
Abstract

The Glucose Management Indicator (GMI) is a biomarker of glycemic control which estimates hemoglobin A1c (HbA1c) based on the average glycemia recorded by continuous glucose monitoring sensors (CGMS). The GMI provides an immediate overview of the patient's glycemic control, but it might be biased by the patient's sensor wear adherence or by the sensor's reading errors. This study aims to evaluate the GMI's performance in the assessment of glycemic control and to identify the factors leading to erroneous estimates. In this study, 147 patients with type 1 diabetes, users of CGMS, were enrolled. Their GMI was extracted from the sensor's report and HbA1c measured at certified laboratories. The median GMI value overestimated the HbA1c by 0.1 percentage points ( = 0.007). The measurements had good reliability, demonstrated by a Cronbach's alpha index of 0.74, an inter-item correlation coefficient of 0.683 and an inter-item covariance between HbA1c and GMI of 0.813. The HbA1c and the difference between GMI and HbA1c were reversely associated (Spearman's r = -0.707; < 0.001). The GMI is a reliable tool in evaluating glycemic control in patients with diabetes. It tends to underestimate the HbA1c in patients with high HbA1c values, while it tends to overestimate the HbA1c in patients with low HbA1c.

摘要

血糖管理指标(GMI)是一种血糖控制的生物标志物,它基于连续血糖监测传感器(CGMS)记录的平均血糖水平来估算糖化血红蛋白(HbA1c)。GMI能即时提供患者血糖控制的总体情况,但可能会受到患者传感器佩戴依从性或传感器读数误差的影响而产生偏差。本研究旨在评估GMI在评估血糖控制方面的性能,并确定导致估计错误的因素。在本研究中,招募了147名使用CGMS的1型糖尿病患者。从传感器报告中提取他们的GMI,并在经认证的实验室测量HbA1c。GMI的中位数高估了HbA1c 0.1个百分点( = 0.007)。测量具有良好的可靠性,Cronbach's alpha指数为0.74、项间相关系数为0.683以及HbA1c与GMI之间的项间协方差为0.813均证明了这一点。HbA1c与GMI和HbA1c之间的差值呈负相关(Spearman's r = -0.707; < 0.001)。GMI是评估糖尿病患者血糖控制的可靠工具。它往往会低估高HbA1c值患者的HbA1c,而倾向于高估低HbA1c值患者的HbA1c。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/7de969a0e241/biosensors-15-00190-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/e6cec1f7da6e/biosensors-15-00190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/8da0f4f97815/biosensors-15-00190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/c00e68105793/biosensors-15-00190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/9b2ee7955ce7/biosensors-15-00190-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/d73f0b6c0a9d/biosensors-15-00190-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/7c5ce235bdb3/biosensors-15-00190-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/b324a69707e4/biosensors-15-00190-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/7de969a0e241/biosensors-15-00190-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/e6cec1f7da6e/biosensors-15-00190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/8da0f4f97815/biosensors-15-00190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/c00e68105793/biosensors-15-00190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/9b2ee7955ce7/biosensors-15-00190-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/d73f0b6c0a9d/biosensors-15-00190-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/7c5ce235bdb3/biosensors-15-00190-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/b324a69707e4/biosensors-15-00190-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/11940097/7de969a0e241/biosensors-15-00190-g008.jpg

相似文献

1
The Usefulness of the Glucose Management Indicator in Evaluating the Quality of Glycemic Control in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring Sensors: A Cross-Sectional, Multicenter Study.使用连续血糖监测传感器评估1型糖尿病患者血糖控制质量时血糖管理指标的效用:一项横断面多中心研究
Biosensors (Basel). 2025 Mar 16;15(3):190. doi: 10.3390/bios15030190.
2
Continuous glucose monitoring systems for type 1 diabetes mellitus.1型糖尿病的连续血糖监测系统
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD008101. doi: 10.1002/14651858.CD008101.pub2.
3
Improvements in Glycemic Control With a Digital Diabetes Logbook: Secondary Analysis of a Randomized Controlled Trial Enriched by Observational, Real-World Data.使用数字糖尿病日志改善血糖控制:一项纳入观察性真实世界数据的随机对照试验的二次分析
J Med Internet Res. 2025 Jun 30;27:e68933. doi: 10.2196/68933.
4
Diabetes self-management smartphone application: Could it be an alternative for continuous glucose monitoring in low resource settings?糖尿病自我管理智能手机应用程序:它能否成为资源匮乏地区持续血糖监测的替代方案?
Prim Care Diabetes. 2025 Apr;19(2):157-164. doi: 10.1016/j.pcd.2025.02.002. Epub 2025 Feb 6.
5
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.用于管理1型糖尿病患者血糖水平的集成式传感器增强泵治疗系统[美敦力MiniMed® Paradigm™ Veo系统以及Vibe™和G4® PLATINUM连续血糖监测(CGM)系统]:一项系统综述与经济学评估
Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170.
6
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.孕前患有糖尿病的女性孕期血糖监测技术。
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3.
7
In Search of the Ideal Resistance Training Program to Improve Glycemic Control and its Indication for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.寻找改善 2 型糖尿病患者血糖控制的理想抗阻训练方案及其适应证:系统评价和荟萃分析。
Sports Med. 2016 Jan;46(1):67-77. doi: 10.1007/s40279-015-0379-7.
8
Treatment of periodontitis for glycaemic control in people with diabetes mellitus.糖尿病患者牙周炎治疗与血糖控制。
Cochrane Database Syst Rev. 2022 Apr 14;4(4):CD004714. doi: 10.1002/14651858.CD004714.pub4.
9
Does the OP5 Automated Insulin Delivery System Close the Gap in Glycemic Control Between White and Black Youth with Type 1 Diabetes?OP5自动胰岛素输送系统能否缩小1型糖尿病白人青年和黑人青年在血糖控制方面的差距?
Diabetes Technol Ther. 2025 Jun;27(6):469-478. doi: 10.1089/dia.2024.0612.
10
The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review.持续皮下血糖监测(CGMS)与间歇性全血指尖血糖监测(SBGM)对1型糖尿病患者糖化血红蛋白(HBA1c)水平的影响:一项系统评价。
Diabetes Res Clin Pract. 2008 Jul;81(1):79-87. doi: 10.1016/j.diabres.2008.02.014. Epub 2008 Apr 15.

本文引用的文献

1
Global, regional, and national burden of type 1 diabetes in adolescents and young adults.全球、区域和国家青少年及青年1型糖尿病负担
Pediatr Res. 2025 Feb;97(2):568-576. doi: 10.1038/s41390-024-03107-5. Epub 2024 Mar 5.
2
Oxidative stress's impact on red blood cells: Unveiling implications for health and disease.氧化应激对红细胞的影响:揭示其与健康和疾病的关系。
Medicine (Baltimore). 2024 Mar 1;103(9):e37360. doi: 10.1097/MD.0000000000037360.
3
The Glucose Management Indicator: Time to Change Course?血糖管理指标:是时候改变方向了?
Diabetes Care. 2024 Jun 1;47(6):906-914. doi: 10.2337/dci23-0086.
4
Correlation Between Glycemic Variability and Diabetic Complications: A Narrative Review.血糖变异性与糖尿病并发症之间的相关性:一篇叙述性综述。
Int J Gen Med. 2023 Jul 21;16:3083-3094. doi: 10.2147/IJGM.S418520. eCollection 2023.
5
Personalized Glycated Hemoglobin in Diabetes Management: Closing the Gap with Glucose Management Indicator.糖尿病管理中的个体化糖化血红蛋白:用葡萄糖管理指标缩小差距。
Diabetes Technol Ther. 2023 Jun;25(S3):S65-S74. doi: 10.1089/dia.2023.0146.
6
Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes.糖化血红蛋白之外:探索糖尿病管理中的连续血糖监测指标
Endocr Connect. 2023 Jun 26;12(7). doi: 10.1530/EC-23-0085. Print 2023 Jul 1.
7
Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations.使用连续血糖监测仪管理1型糖尿病:进展、挑战与建议。
Pharmgenomics Pers Med. 2023 Mar 31;16:263-276. doi: 10.2147/PGPM.S374663. eCollection 2023.
8
Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine.1型糖尿病与自身免疫性疾病:对两者关联及个性化医疗应用的批判性综述
J Pers Med. 2023 Feb 26;13(3):422. doi: 10.3390/jpm13030422.
9
Acute Hepatitis of Unknown Origin in Pediatric Age Group: Recent Outbreaks and Approach to Management.儿童年龄组不明原因急性肝炎:近期疫情及管理方法
J Clin Med. 2022 Dec 20;12(1):9. doi: 10.3390/jcm12010009.
10
Sex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: A Mendelian randomization study.空腹血糖与糖化血红蛋白关联的性别差异及其对死亡率的影响:一项孟德尔随机研究。
EBioMedicine. 2022 Oct;84:104259. doi: 10.1016/j.ebiom.2022.104259. Epub 2022 Sep 27.